Zepbound vs Wegovy: Which Is Right for You?

If you’re weighing Zepbound vs Wegovy, you’re comparing two of the most effective weight-loss medications available today. Both are once-weekly GLP-1 shots, both are FDA-approved for chronic weight management, and both can deliver real results. Still, they differ in how they work, how much weight people lose on average, what they cost, and how they feel day to day. This guide breaks down the key differences so you can have a more informed conversation with your provider.

Zepbound vs Wegovy: The Quick Answer

Short on time? Here’s the summary before we dig into the details:

• Zepbound (tirzepatide): Made by Eli Lilly. It targets two gut hormones (GIP and GLP-1). In head-to-head research, it produced more weight loss on average.
• Wegovy (semaglutide): Made by Novo Nordisk. It targets one hormone (GLP-1). It has a longer track record and approved cardiovascular benefits.
• Bottom line: Zepbound led to greater average weight loss in a direct trial, but the right choice depends on your health history, insurance, side effects, and what your provider recommends.

How Each Medication Works

When comparing Zepbound vs Wegovy, the mechanism is the first real difference. Both calm appetite and slow digestion, yet they do it through slightly different pathways.

How Zepbound works

Zepbound contains tirzepatide, a dual agonist that activates both GIP and GLP-1 receptors. Because it works on two pathways at once, it can strongly reduce hunger and help you feel full on less food.

How Wegovy works

Wegovy contains semaglutide, a GLP-1 receptor agonist. It mimics a hormone your body releases after eating, which curbs appetite and helps regulate blood sugar. Semaglutide has been studied for years, first for type 2 diabetes and later for weight loss.

Weight-Loss Results: What the Research Shows

The biggest reason people compare these two drugs is simple: which one works better? In 2025, the SURMOUNT-5 trial put them head to head in 751 adults with obesity or overweight. Over 72 weeks, the results favored Zepbound:

• Zepbound: about 20.2% average body-weight loss (roughly 50 lbs)
• Wegovy: about 13.7% average body-weight loss (roughly 33 lbs)
• Nearly twice as many Zepbound users lost 25% or more of their body weight

In short, tirzepatide produced greater average weight loss in this study. However, individual results vary widely, and many people reach their goals on either medication. You can review a detailed clinical breakdown in this GoodRx comparison.

Dosing and Weekly Schedules

Both medications are once-weekly injections you can use at home, and both start low and increase gradually to limit side effects.

• Zepbound: Six strengths from 2.5 mg up to 15 mg. You typically begin at 2.5 mg and step up every four weeks as tolerated.
• Wegovy: Five doses from 0.25 mg up to 2.4 mg, usually titrated over about 16 weeks.

Whichever you use, consistency matters more than perfection. Logging each dose helps you stay on schedule and spot patterns over time, and you can track it free with Pep.

Cost of Zepbound vs Wegovy

Price is often the deciding factor. As of 2026, list prices land in a similar range, although self-pay options have shifted quickly:

• Zepbound: roughly $1,086 per month at list price, with lower-cost single-dose vials available through the manufacturer’s self-pay program.
• Wegovy: roughly $1,349 per month at list price, with discounted self-pay pricing for new patients on starter doses.

Your actual cost depends heavily on insurance coverage, manufacturer savings cards, and pharmacy. Because prices and programs change often, confirm current numbers with your pharmacy or each manufacturer before you decide.

Side Effects to Expect

These two drugs share a similar side-effect profile because both slow digestion. Most effects are mild to moderate, and they tend to ease as your body adjusts. Common ones include:

• Nausea, especially in the first weeks or after a dose increase
• Diarrhea, constipation, or indigestion
• Fatigue or burping

Both also carry a boxed warning about a rare thyroid tumor risk, so they aren’t right for everyone. For practical relief strategies, see our guides on managing GLP-1 side effects and reducing nausea on GLP-1s.

How to Choose Between Zepbound and Wegovy

There’s no universal winner in the Zepbound vs Wegovy debate, only the option that fits you best. Weigh these factors with your provider:

• Coverage: Which one does your insurance approve, and at what copay?
• Health history: Wegovy has approved cardiovascular benefits, so your conditions may steer the choice.
• Tolerance: Some people simply feel better on one medication than the other.
• Goals: If maximum average weight loss is the priority, the data leans toward Zepbound.

Whichever you choose, tracking your doses, weight, and symptoms makes a real difference. Many users log their journey with the Zepbound tracker or Wegovy tracker in Pep, then pair it with our guide to GLP-1 weight loss for realistic expectations.

Frequently Asked Questions

Is Zepbound or Wegovy better for weight loss?

In the SURMOUNT-5 trial, Zepbound produced more average weight loss than Wegovy. Even so, the better pick in the Zepbound vs Wegovy comparison depends on your insurance, side effects, and provider guidance.

Can you switch between Zepbound and Wegovy?

Many people do switch, often because of cost, coverage, or tolerance. Your provider will guide the timing and starting dose so you transition safely.

Are Zepbound and Wegovy the same type of drug?

Not exactly. Both are GLP-1 based weekly shots, but Zepbound (tirzepatide) also targets GIP, while Wegovy (semaglutide) targets GLP-1 alone.

This article is for educational purposes only and is not medical advice. Talk with a qualified healthcare provider before starting, stopping, or switching any medication.